Pyxis Oncology Inc (PYXS) has gained Monday morning, with the stock climbing 10.63% in pre-market trading to 1.77. PYXS's short-term technical score of 61 indicates that the stock has traded more bullishly over the last month than 61% of stocks on the market. In the Biotechnology industry, which ranks 135 out of 146 industries, PYXS ranks higher than 84% of stocks. Pyxis Oncology Inc has fallen 25.93% over the past month, closing at $2.12 on August 28. During this period of time, the stock fell as low as $1.60 and as high as $2.46. PYXS has an average analyst recommendation of Strong Buy. The company has an average price target of $9.60.
PYXS has an Overall Score of 57. Find out what this means to you and get the rest of the rankings on PYXS!